Key Insights from EULAR 2022: An Interdisciplinary Expert Roundtable Discussion

7th July 2022

Watch our roundtable discussion, now available here on the EMJ website, to gain a deeper understanding of emerging data from the European Alliance of Associations for Rheumatology (EULAR) 2022 congress as well as real-world evidence on biosimilars.

Key Insights from EULAR 2022: An Interdisciplinary Expert Roundtable Discussion

Patients Commencing Disease-Modifying Antirheumatic Drugs Should Be Screened for Infections

Can Artificial Intelligence Aid Kawasaki Disease Diagnosis?

More articles

Infographic: Osteoarthritis - Redefining the Way We Consider This Chronic Condition

Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis

Immune Relevant Behavioural Interventions: Immunological Evidence as an Integral Measure of Behavioural Interventions for Rheumatic Diseases, a Review of Current Research

Featured journals

EMJ Rheumatology 9 [Infographic 1] 2022

EMJ Rheumatology 9.1 2022

Therapeutic Area

About Us

Key Insights from EULAR 2022: An Interdisciplinary Expert Roundtable Discussion

Related To This Subject

Patients Commencing Disease-Modifying Antirheumatic Drugs Should Be Screened for Infections

Can Artificial Intelligence Aid Kawasaki Disease Diagnosis?

More articles

Infographic: Osteoarthritis - Redefining the Way We Consider This Chronic Condition

Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis

Immune Relevant Behavioural Interventions: Immunological Evidence as an Integral Measure of Behavioural Interventions for Rheumatic Diseases, a Review of Current Research

Featured journals

EMJ Rheumatology 9 [Infographic 1] 2022

EMJ Rheumatology 9.1 2022

Join our mailing list